Switch theme
Sign up to access all valuation multiples
Terveystalo PLC o is a healthcare service provider in Finland. The company offers primary and specialized healthcare services to corporate, private, and public sector customers. Its healthcare service offering includes general practice and specialist medical care, diagnostic services, outpatient surgery, dental services and other adjacent services; it covers the entire integrated treatment chain of healthcare. The Group comprises of three reporting segments: Healthcare Services, Portfolio Businesses, and Sweden, out of which it derives maximum revenue from Healthcare Services segment.
2001
9.2K+
LTM Revenue $1.5B
LTM EBITDA $261M
$2.1B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Terveystalo has a last 12-month revenue of $1.5B and a last 12-month EBITDA of $261M.
In the most recent fiscal year, Terveystalo achieved revenue of $1.4B and an EBITDA of $234M.
Terveystalo expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Terveystalo valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $1.4B | $1.4B | XXX | XXX | XXX |
| Gross Profit | $788M | $806M | XXX | XXX | XXX |
| Gross Margin | 57% | 56% | XXX | XXX | XXX |
| EBITDA | $97.3M | $234M | XXX | XXX | XXX |
| EBITDA Margin | 7% | 16% | XXX | XXX | XXX |
| Net Profit | $26.2M | -$45.3M | XXX | XXX | XXX |
| Net Margin | 2% | -3% | XXX | XXX | XXX |
| Net Debt | $407M | $403M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Terveystalo's stock price is EUR 12 (or $12).
Terveystalo has current market cap of EUR 1.5B (or $1.6B), and EV of EUR 2.0B (or $2.1B).
See Terveystalo trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.1B | $1.6B | XXX | XXX | XXX | XXX | $0.70 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Terveystalo has market cap of $1.6B and EV of $2.1B.
Terveystalo's trades at 1.5x LTM EV/Revenue multiple, and 8.1x LTM EBITDA.
Analysts estimate Terveystalo's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Terveystalo and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $2.1B | XXX | XXX | XXX |
| EV/Revenue | 1.5x | XXX | XXX | XXX |
| EV/EBITDA | 9.1x | XXX | XXX | XXX |
| P/E | 20.4x | XXX | XXX | XXX |
| P/E/Growth | 0.7x | XXX | XXX | XXX |
| EV/FCF | 10.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpTerveystalo's NTM/LTM revenue growth is 3%
Terveystalo's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Terveystalo's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Terveystalo's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Terveystalo and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 16% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 140% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 19% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 50% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Compass Pathways | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Terveystalo acquired XXX companies to date.
Last acquisition by Terveystalo was XXXXXXXX, XXXXX XXXXX XXXXXX . Terveystalo acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Terveystalo founded? | Terveystalo was founded in 2001. |
| Where is Terveystalo headquartered? | Terveystalo is headquartered in Finland. |
| How many employees does Terveystalo have? | As of today, Terveystalo has 9.2K+ employees. |
| Who is the CEO of Terveystalo? | Terveystalo's CEO is Mr. Ville Iho. |
| Is Terveystalo publicy listed? | Yes, Terveystalo is a public company listed on HEL. |
| What is the stock symbol of Terveystalo? | Terveystalo trades under TTALO ticker. |
| When did Terveystalo go public? | Terveystalo went public in 2017. |
| Who are competitors of Terveystalo? | Similar companies to Terveystalo include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Terveystalo? | Terveystalo's current market cap is $1.6B |
| What is the current revenue of Terveystalo? | Terveystalo's last 12-month revenue is $1.5B. |
| What is the current EBITDA of Terveystalo? | Terveystalo's last 12-month EBITDA is $261M. |
| What is the current EV/Revenue multiple of Terveystalo? | Current revenue multiple of Terveystalo is 1.5x. |
| What is the current EV/EBITDA multiple of Terveystalo? | Current EBITDA multiple of Terveystalo is 8.1x. |
| What is the current revenue growth of Terveystalo? | Terveystalo revenue growth between 2023 and 2024 was 4%. |
| Is Terveystalo profitable? | Yes, Terveystalo is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
